Fundamental Analysis
52 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +51.4% | +4.1% | 2 / 3 | +10.5% | -3.38 pp | +3.84 pp | +19.1% | 0.22 | 3.86 | 205 | +10,5% | 20,3 | +80,4% | 3.86 | 3.18 | +21,3% |
| Pts | 8 | 0 | 8 | 4 | 0 | 12 | 8 | 12 | 4 | |||||||
Valuation annotation:Price: 12.000 (close price on 2026-10-19)EPS (TTM): 3.110
Financial charts
1.Revenue & growth
VND bn205Q2/26
1.Revenue & growth
VND bn205Q2/26
2.Profit & growth
VND bn20,3Q2/26
3.Profit mix (Penman)
VND bn46,4Q2/26
4.Margins & cost structure
%9.9%Q2/26
5.Returns & cash cycle
% · days14.2%Q2/26
6.Earnings quality & cash
VND bn
7.Asset structure
VND bn320Q2/26
8.Funding & debt health
VND bn · times320Q2/26
9.Revenue backlog
VND bn1,20Q2/26
10.Valuation
times · %4,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.460Q2/26
Adjusted EPS growth, latest quarter
44.8%
Average adjusted EPS growth, 3 quarters
-5.1%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
4.5%
Source: vnstockData through Q2/26